Mice
C57BL/6JArc, B6.CH-2bm-1 (BM-1), OT-II(47) x Ly5.1 and
OT-I(48) x Ly5.1, Flt3ITD/ITD (21), and
IAα-/- mice (49) were used at 6 - 12 weeks of age. All
mice were bred and maintained in specific pathogen–free conditions at
the Melbourne Bioresources Platform at Bio21 Molecular Science and
Biotechnology Institute. Experimental procedures were approved by the
Animal Ethics Committee of the University of Melbourne (protocol no.
1714375).